#hcsmeu

Screen Shot 2013-10-06 at 11.09.19

#hcsmeu discussions archive

Transcripts are embedded in the dates below; further information and analytics are available here.

A history of #hcsmeu is available here.

#148 21 October 2014 Themed chat: patient involvement at health policy, commercial (e.g. digital pharma), and medical conferences. Moderated by Andrew Spong and Len Starnes

#147 28 February 2014 Themed chat for #RareDiseaseDay: data challenges in understanding rare disease, striking a balance between patient anonymity and open data on collaboration on rare disease treatment, and what pharma can do to better support the rare disease community. Moderated by pharmaphorum, who published a post introducing the event.

#146 18 October 2013 Themed chat: the use of Twitter & tweet chats at professional medical conferences

#145 6 September 2013 Themed chat: patient-facing sources of health information on the Internet and social web

#144 21 June 2013 Themed chat: could a social, global electronic health record be the next facebook?

#hcsmeu ceased to be a weekly tweetchat in October 2012, and evolved into a discussion and information-sharing hashtag, with occasional themed chats.

#143 28 Sep 2012  (google+, usage, software houses and healthcare whats going on)

#142 22 June 2012 (“Open data” possible for eHealth, need to see a change in corp culture for Soc Med to be effective?)

#141 15 June 2012

#140 08 June 2012  (Usefulness of HC platforms to physicians;Impact of digital&SocMed to mothers’ roles; Online info really secure?)

#139

#138

#137 18 May 2012  (More strict promotion to the devices ind. what implications for patients?; Google knowledge graph)

#136 11 May 2012 (questions to determine patient health literacy, ABPI: what the words consumption, purchase and recommendation mean for pharma)

#135 4 May 2012 (Improving Diabetapedia, tablets in sales rep meetings, eHealth infographics)

#134 27 April 2012 (Improving digital literacy; pharma’s first “Digital Prescribing Information”; HCP expectations of interactive publications)

#133 20 April 2012 (Pharma future in digital; how long before patient have full access to their data; patietns to sue generic makers)

#132 13 April 2012 (Pharma online activities that help/support HCPs;WOM as a criteria in HCP recommendation; Business value of Psoriasis360 to Janssen)

#131 30 March 2012 (webcasting surgery, dr/pt working together with online tools, has regulation had its day in pharma)

#130 23 March 2012 (Psoriasis360 facebook withdrawal & Pharma’s future on facebook; SMS tools and patient compliance)

#129 16 March 2012 (iPad resolution & medical apps; SXSW health track review; Pharma CEOs and patient engagement)

#128 9 March 2012 (What is a social business; Why isn’t social media growing in h/c business?)

#127 2 March 2012 (Monitoring Twitter for research; Facebook template/timeline changes & patient engagement; Differences in SM use in EU vs. US)

#126 24 February 2012 (patient advocacy groups & epatient needs; pharma CEOs use of SM during crises; wearable devices: hype or hope?)

#125 17 February 2012 (Pinterest & healthcare, Google Health search changes: pt/HCP perspectives; AZ Arimidex DTC sales for other drugs/geogs)

#124 10 February 2012 (Which are best portals for HCPs in EU, how can pharma build trust with external people?)

#122 3 February 2012(Will Pharma survive crises before turning to soc Med; launch of inn.new tech prod into pharma; hcsmeu an ass. with membership fees?)

#121 27.January 2012 (Twitter business/privat; reco twittertraining for pharma; a pharma rep 2.0 looks like?)

#120 20 January 2012(Pharma monitoring/mod of sponsored communities; pharma payments to celebs; informed pt care & cost to uniformed pt care)

#119 13 January 2012 (Regulation of mobile apps, soc. med. apps for pt support, twitter for patient safety)

#118 6 January 2012 (New FDA guidance re. off-label inquiries; SM in healthcare: most relevant at POC?; what will change in social health in 2012)

#117 16 December 2011 (Best healthcare engagement in 2011; HCSM and innovation in care; pharma innovation during a recession)

#116 9 December 2011(IBM’s Watson: healthcare applications; Should patients opt in or out to sharing their data; new devs in pt adherence)

#115 2 December 2011 (next wave of HCPs on the social web; pharma’s ID of thought leaders via SM; developments in patient adherence)

#114 25 November 2011 (hearing the patient voice indirectly, clinical assessment via soc. med. and the Olympics and health)

#113 18 November 2011 (social media and immigrant populations; data storage policies from Google etc and SM in pharma; games vs gamification)

#112 11 November 2011 (Pharma and Adwords; DTC ads are dead, so what’s next?; Will biosimilars help patients or only pharma?)

#111 4 November 2011 (pharma’s Twitter performance vs. other industries; innovation in care as a yardstick; are we too focused on patients?)

#110 28 October 2011 (moving SM from conversation to a change agent; Gamefication; The evolving role of HCPs in SM)

#109 21 October(DTC & patient empowerment; Are all patients “e”; social across pharma enterprise; from pharma engagement to consumers channel expectations)

#108 14 October 2011 (SM/digital & co-op btwn orgs at regional lvl; impact of biz/work on health in US vs EU; revised EU proposals on info to patients from industry)

#107 7 October 2011 (pharma involvement in patient blogs;new facebook features from healthcare POV; healthdata gatekeeper: doc, patient, gov)

#106 30 September 2011 (pharma SM: PR vs regltry concerns; leaders & laggards in pharma digital; pts who prefer interventionistic care)

#105 23 September 2011 (Physician portal uptake in the EU; HCP SM discussions – patients or peers; time HCPs commit to communities)

#104 16 September 2011 (Is the HCP-pt relationship really evolving; SM & clinical trial recruitment)

#103 9 September 2011 (Role of SM in the future of healthcare; regulation of healthcare and limitations of SM’s benefits)

#102 2 September 2011 (pharma digi mktg org; healthcare professional networks and pharma; personalized health info vs. privacy)

#101 26 August 2011 (M3’s acquisition of doctors.net.uk; definitions of ‘health’; facebook layout: too vanilla for pharma?)

#100 19 August 2011 (Pharma facebook activity, one week on from 15/8 changes; EU cookie law & pharma websites; Pharma/hc conferences & social tech)

#99 12 August 2011 (facebook comment changes; corporate opinions of reputation of SM; new advertising formats for Pharma)

#98 5 August 2011 (Patients communicating with pharma abt indiv needs via SM; augmented reality and healthcare marketing; barriers to patient advocate participation in prof conferences)

#97 29 July 2011 (Patients ‘firing’ HCPs and evolution of HCP-patient relations; How will HCSM tools & svcs scale)

#96 22 July 2011 (What should be in a hcsmeu app; Relationship between Enterprise 2.0 & hcsm; PR vs digital agencies for hcsm campaign dev)

#95 15 July 2011 (ePatient use of Google+; LinkedIn as HCP community conversation driver; Social media and professional learning)

#94 8 July 2011 (Graphic healthcare images on fb; Pharma fb comment strategies; SM as pure comms vs. ‘big data’ & revolutionising of healthcare)

#93 1 July 2011 (The diabetes-heavy nature of Dosie awards; Social media risk tolerance; HCSM & inequality of access)

#92 24 June 2011 (HCP communities & member data privacy; value of promoted tweets; strategies to teach social to new users)

#91 17 June 2011 (Govts’ responsibility to help elders with tech; Pharma, patients and mobile tech; Twitter/social use at prof conferences)

#90 10 June 2011 (Twitter & public health campaigns; fair SM practice principles; when your boss asks: ‘how is SM in pharma making us money?’)

#89 3 June 2011 (Relative maturity of Pharma marketing across subsidiaries; Pharma answers to HCP, patient questions within SM; SM and privacy)

#88 27 May 2011 (Pharma & HC org use of SM to promote adherence; #hcsmgate; new and unusual job titles appearing within Pharma)

#87 20 May 2011 (Pharma handling of SM AEs; Conference Twitter use; HCP professional use of Twitter)

#86 13 May 2011(Nurse uptake of SM; pharma SM advocate exodus; need for medical advice on OTC supplements)

#85 6 May 2011 (Using SM to involve patients, HCPs in pharma innovation; evidence that SM improves adherence; health info ‘master switch’ ownership on the web)

#84 15 April 2011 (Consumer tech & the clinician workflow; integrating digital into govt health strategies; hcp-patient relationship in age of participatory medicine)

#83 8 April 2011 (‘Trust filters’ for patient health info; hcp contributions to making health info reliable & trustworthy; response to PMCPA guidance)

#82 1 April 2011 (ePatient connections topics; latest FDASM guidance delay; iterating what can go wrong for Pharma in SM)

#81 24 March 2011 (Patients: from informed consent to informed choice; Where are pharmacists in SM?; Celebrity SM & raising awareness around disease states)

#80 17 March 2011 (Pharma-sponsored SM initiatives for nurses; Evidence base for SM’s influence on adherence; Dealing with a SM crisis)

#79 10 March 2011 (Impact of EU tracking requirements on SM initiatives; Supporting claims with evidence in social context; SM & representing the ‘hard to reach’

#78 3 March 2011 (Your €100K patient campaign; Web 1.0 success: a precondition for Web 2.0 success?; pharma and building trust with payers)

#77 25 February 2011 (EU medical congress use of SM; EU medical congresses & the patient voice; Rare Disease Day (28/2) SM activities)

#76 18 February 2011 (@AstraZenecaUS’s #RXsave; Web influence of public opinion re disease states & therapy options; corp SM essential elements)

#75 11 February 2011 (Assessing the trustworthiness of #hcsm resources; #hcsmeu as the voice of all EU partners in health; the best ways for patients to contribute to #hcsm)

#74 4 February 2011

#73 28 January 2011

#72 21 January 2011

#71 14 January 2011

#70 7 January 2011

#69 17 December 2010

#68 10 December 2010

#67 3 December 2010

#66 26 November 2010

#65 19 November 2010

#64 12 November 2010

#63 5 November 2010

#62 29 October 2010

#61 22 October 2010

#60 15 October 2010

#59 8 October 2010

#58 1 October 2010

#57 24 September 2010

#56 17 September 2010

#55 10 September 2010

#54 3 September 2010

#53 27 August 2010

#52 20 August 2010

#51 13 August 2010

#50 6 August 2010

#49 30 July 2010

#48 23 July 2010

#47 16 July 2010

#46 9 July 2010

#45 2 July 2010

#44 25 June 2010

#43 18 June 2010

#42 11 June 2010

#41 4 June 2010

#40 28 May 2010

#39 21 May 2010

#38 14 May 2010

#37 7 May 2010

#36 30 April 2010

#35 23 April 2010

#34 16 April 2010

#33 9 April 2010

29 March – 4 April #hscmeucamp 1 archive and review

#32 26 March 2010

#31 19 March 2010

#30 12 March 2010

#29 5 March 2010

#28 26 February 2010

#27 19 February 2010

#26 12 February 2010 (hcscmeucamp.com announced)

#25 5 February 2010

#24 29 January 2010

#23 22 January 2010

#22 15 January 2010

#21 No archive currently available

#20 18 December (hcsmeu.com announced)

#19 11 December

#18 4 December

#17 27 November

#16 20 November

#15 13 November

#14 6 November 2009

#13 30 October 2009

#12 23 October 2009

#11 16 October 2009

#10 9 October 2009

#9 2 October 2009

#8 25 September 2009

#7 18 September 2009

#6 11 September 2009

#5 4 September 2009

#4 28 August 2009

#3 21 August 2009

#2 14 August 2009

#1 7 August 2009

4 thoughts on “#hcsmeu

  1. Pingback: Virology in healthcare social media | Aurora Comms Blog

  2. Pingback: Writing up #hcsmeu tweet-ups | Aurora Comms Blog

  3. Pingback: Can Twitter groups be effective for business discussion? | pharmaphorum

  4. Pingback: Virology in healthcare social media « Aurora Comms Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s